S-892216-PO
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-892216-PO, covering 2025-10-30 to 2025-10-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls [Phase 1]